Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Merit Medical Systems (MMSI) EBIAT (2016 - 2025)

Merit Medical Systems' EBIAT history spans 16 years, with the latest figure at $38.0 million for Q4 2025.

  • For Q4 2025, EBIAT rose 35.99% year-over-year to $38.0 million; the TTM value through Dec 2025 reached $128.5 million, up 6.76%, while the annual FY2025 figure was $128.5 million, 6.76% up from the prior year.
  • EBIAT for Q4 2025 was $38.0 million at Merit Medical Systems, up from $27.8 million in the prior quarter.
  • Across five years, EBIAT topped out at $38.0 million in Q4 2025 and bottomed at -$44.1 million in Q4 2022.
  • The 5-year median for EBIAT is $24.2 million (2023), against an average of $19.8 million.
  • The largest annual shift saw EBIAT surged 671.47% in 2021 before it tumbled 314.04% in 2022.
  • A 5-year view of EBIAT shows it stood at $20.6 million in 2021, then crashed by 314.04% to -$44.1 million in 2022, then soared by 171.32% to $31.5 million in 2023, then fell by 11.19% to $27.9 million in 2024, then skyrocketed by 35.99% to $38.0 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's EBIAT are $38.0 million (Q4 2025), $27.8 million (Q3 2025), and $32.6 million (Q2 2025).